Photo credit: Oncology Analytics
November 8, 2018
Earlier this week Oncology Analytics, a technology company focused on helping organizations apply and manage benefits for cancer care, announced that it closed a $21 million Series B funding round. The new round was led by Oak HC/FT with participation from McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage.
The company said the new money will help it expand its...
March 2, 2018
Artificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health Oncology, that uses EMR data to provide practical AI applications for real oncology use cases.
“Our team of healthcare professionals is using the deep clinical oncology dataset at...
February 15, 2018
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had already invested into the company in 2016, and as a result of the deal will control all shares of Flatiron Health.
“This is an important step in our personalized healthcare...
October 18, 2017
Two years after launching its smoking cessation app Quitter's Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It's also applying the lessons learned from Quitter's Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy...
January 21, 2016
Cedars-Sinai Medical Center is embarking on a small study to see if a Fitbit Charge HR can help oncologists assess whether their patients are active enough for chemotherapy.
“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” Dr. Arvind Shinde, a faculty physician in the departments of...
September 30, 2015
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
June 16, 2015
Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care. That was the theme that ran through the morning conversation in the digital health track at the 2015 BIO International Convention, a pharma and life sciences-focused conference held in Philadelphia this week.
“We’re in a disruptive time. We’re in a time of moonshots, when...
May 14, 2015
Correction: This article previously mentioned strategic investors in MedoPad. The reference has been removed, as the companies in question were not actually investors.
A London hospital is the latest to put the Apple Watch to use within its walls, this time to improve medication management and adherence for cancer patients undergoing chemotherapy. According to a report from Wareable, King's...
July 30, 2014
Smartphone and tablet use by level of experience.
A new study in the Journal of Radiation Oncology looked at self-reported smartphone and tablet ownership and usage statistics in young, French, radiation oncologists. While the sample is quite specific and not necessarily generalizable, it does present an interesting look at the up-and-coming generation of physicians (most of the subjects had...
April 10, 2014
Boston-based PatientsLikeMe, a hub for crowd-sourced patient data and an open research platform, has announced its most wide-reaching pharma partnership yet, a five-year agreement to share data with Genentech, a division of Roche.
"They are a forward-looking company in the health IT space, and ... I think they're really looking at new forms of evidence and how that can improve their business and...